Executive Access - Leadership Impact

Challenge

A rare disease biotech in Europe was preparing for a pivotal Phase III trial and urgently needed a Chief Medical Officer with both deep therapeutic expertise and the leadership ability to navigate complex patient pathways. Previous search efforts had produced candidates who looked right on paper but lacked the empathy, drive, and strategic thinking the role demanded.

Our Approach

HNH activated its specialist leadership network across biotech, pharma, and medtech - going beyond database searches to identify proven leaders through trusted referrals and deep industry connections. Every introduction was evaluated not just for technical expertise, but for the strategic contribution and cultural alignment the candidate would bring to the organisation.

Rather than flooding the company with CVs, HNH focused on a targeted shortlist of leaders who had demonstrated their ability to deliver in similar high-stakes environments. Each candidate was assessed for leadership fit, understanding of the disease area, and capacity to accelerate the company's growth trajectory.

Outcome

Within weeks, the company appointed a CMO who delivered from day one - bringing not only the clinical expertise required but also the leadership credibility to strengthen investor confidence and accelerate the trial timeline. The CEO described HNH's insight into their space and genuine partnership as indispensable to their growth story.

The appointed leader went on to successfully navigate the Phase III trial, contributing directly to a significant funding round and positioning the company for commercial readiness.